Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: An overview

Breast Cancer Research

Volumn 6, Issue 6, 2004, Pages 246-254

  Guillemette, Chantal ^a,b   Bélanger, Alain ^a,b   Lépine, Johanie ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Breast carcinoma; Catecholestrogen; Estrogen metabolism; Genetic polymorphism; UDP glucuronosyltransferase

Indexed keywords

CATECHOL ESTROGEN; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN SULFOTRANSFERASE; ESTRONE; ESTRONE SULFATE; GLUCURONOSYLTRANSFERASE; TAMOXIFEN; TESTOSTERONE 17BETA DEHYDROGENASE;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER RISK; DISEASE PREDISPOSITION; ENZYME MECHANISM; ESTRADIOL BLOOD LEVEL; ESTROGEN ACTIVITY; ESTROGEN METABOLISM; ESTROGEN RELEASE; ESTROGEN SYNTHESIS; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GLUCURONIDATION; HUMAN; HYDROXYLATION; METHYLATION; PROTECTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RACE DIFFERENCE; REVIEW; RISK FACTOR;

AGING; BREAST; BREAST NEOPLASMS; ESTRADIOL; ESTROGENS; FEMALE; GLUCURONOSYLTRANSFERASE; HUMANS; RISK FACTORS;

EID: 7444258476     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr936     Document Type: Review

References (90)

1. Key TJ: Serum oestradiol and breast cancer risk. Endocr Relat Cancer 1999, 6:175-180.
2. Thomas HV, Reeves GK, Key TJ: Endogenous estrogen and postmenopausal breast cancer: a quantitative review. Cancer Causes Control 1997, 8:922-928.
3. Endogenous Hormones and Breast Cancer Collaborative Group: Endogenous sex hormones and breast cancer in post-menopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002, 94:606-616.
4. Liehr JG, Ricci MJ: 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc Natl Acad Sci USA 1996, 93: 3294-3296.
5. Castagnetta LA, Granata OM, Traina A, Ravazzolo B, Amoroso M, Miele M, Bellavia V, Agostara B, Carruba G: Tissue content of hydroxyestrogens in relation to survival of breast cancer patients. Clin Cancer Res 2002, 8:3146-3155.
6. Jefcoate CR, Liehr JG, Santen RJ, Sutter TR, Yager JD, Yue W, Santner SJ, Tekmal R, Demers L, Pauley R, et al.: Tissue-specific synthesis and oxidative metabolism of estrogens. J Natl Cancer Inst Monogr 2000, 27:95-112.
7. Brooks SC, Horn L: Hepatic sulfation of estrogen metabolites. Biochim Biophys Acta 1971, 231:233-241.
8. Hobkirk R: Steroid sulfotransferases and steroid sulfate sulfatases: characteristics and biological roles. Can J Biochem Cell Biol 1985, 63:1127-1144.
9. Longcope C, Gorbach S, Goldin B, Woods M, Dwyer J, Warram J: The metabolism of estradiol; oral compared to intravenous administration. J Steroid Biochem 1985, 23:1065-1070.
10. Belanger A, Hum DW, Beaulieu M, Levesque E, Guillemette C, Tchernof A, Belanger G, Turgeon D, Dubois S: Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues. J Steroid Biochem Mol Biol 1998, 65:301-310.
11. Guldberg HC, Marsden CA: Catechol-O-methyl transferase: pharmacological aspects and physiological role. Pharmacol Rev 1975, 27:135-206.
12. Raftogianis R, Creveling C, Weinshilboum R, Weisz J: Estrogen metabolism by conjugation. J Natl Cancer Inst Monogr 2000, 27:113-124.
13. Gestl SA, Green MD, Shearer DA, Frauenhoffer E, Tephly TR, Weisz J: Expression of UGT2BT, a UDP-glucuronosyltransferase implicated in the metabolism of 4-hydroxyestrone and all-trans retinoic acid, in normal human breast parenchyma and in invasive and in situ breast cancers. Am J Pathol 2002, 160:1467-1479.
14. Guillemette C, Millikan RC, Newman B, Housman DE: Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans. Cancer Res 2000, 60:950-956.
15. Guillemette C, De Vivo I, Hankinson SE, Haiman CA, Spiegelman D, Housman DE, Hunter DJ: Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels. Cancer Epidemiol Biomarkers Prev 2001, 10:711-714.
16. Duguay Y, McGrath M, Lepine J, Gagne JF, Hankinson SE, Colditz GA, Hunter DJ, Plante M, Tetu B, Belanger A, et al.: The functional UGT1A1 promoter polymorphism decreases endometrial cancer risk Cancer Res 2004, 64:1202-1207.
17. Adegoke OJ, Shu XO, Gao YT, Cai Q, Breyer J, Smith J, Zheng W: Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer. Breast Cancer Res Treat 2004, 85:239-245.
18. Cecchin E, Russo A, Corona G, Campagnutta E, Martella L, Boiocchi M, Toffoli G: UGT1A1*28 polymorphism in ovarian cancer patients. Oncol Rep 2004, 12:457-462.
19. Sparks R, Ulrich C, Bigler J, Tworoger S, Yasui Y, Rajan K, Porter P, Stanczyk F, Ballard-Barbash R, Yuan X, et al.: UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients. Breast Cancer Res 2004, 6:R488-R498.
20. Labrie F: Intracrinology. Mol Cell Endocrinol 1991, 78:C113-C118.
21. Labrie F, Belanger A, Luu-The V, Labrie C, Simard J, Cusan L, Gomez JL, Candas B: DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging. Steroids 1998, 63:322-328.
22. Labrie F: Extragonadal synthesis of sex steroids: intracrinology. Ann Endocrinol (Paris) 2003, 64:95-107.
23. Szymczak J, Milewicz A, Thijssen JH, Blankenstein MA, Daroszewski J: Concentration of sex steroids in adipose tissue after menopause. Steroids 1998, 63:319-321.
24. Simpson ER, Clyne C, Speed C, Rubin G, Bulun S: Tissue-specific estrogen biosynthesis and metabolism. Ann N Y Acad Sci 2001, 949:58-67.
25. Simpson ER: Aromatization of androgens in women: current concepts and findings. Fertil Steril 2002, 77(suppl 4): 6-S10.
26. Simpson ER: Role of aromatase in sex steroid action. J Mol Endocrinol 2000, 25:149-156.
27. Purohit A, Reed MJ: Regulation of estrogen synthesis in postmenopausal women. Steroids 2002, 67:979-983.
28. Vermeulen A: The hormonal activity of the postmenopausal ovary. J Clin Endocrinol Metab 1976, 42:247-253.
29. Cauley JA, Gutai JP, Sandler RB, LaPorte RE, Kuller LH, Sashin D: The relationship of endogenous estrogen to bone density and bone area in normal postmenopausal women. Am J Epidemiol 1986, 124:752-761.
30. Cauley JA, Lucas FL, Kuller LH, Stone K, Browner W, Cummings SR: Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group. Ann Intern Med 1999, 130: 70-277.
31. Thijssen JH, Blankenstein MA: Endogenous oestrogens and androgens in normal and malignant endometrial and mammary tissues. Eur J Cancer Clin Oncol 1989, 25:1953-1959.
32. Mady EA, Ramadan EE, Ossman AA: Sex steroid hormones in serum and tissue of benign and malignant breast tumor patients. Dis Markers 2000, 16:151-157.
33. Blankenstein MA, van de Ven J, Maitimu-Smeele I, Donker GH, de Jong PC, Daroszewski J, Szymczak J, Milewicz A, Thijssen JH: Intratumoral levels of estrogens in breast cancer. J Steroid Biochem Mol Biol 1999, 69:293-297.
34. Chatterton RT Jr, Geiger AS, Gann PH, Khan SA: Formation of estrone and estradiol from estrone sulfate by normal breast parenchymal tissue. J Steroid Biochem Mol Biol 2003, 86: 59-166.
35. Zhu BT, Conney AH: Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 1998, 19:1-27.
36. Lee AJ, Cai MX, Thomas PE, Conney AH, Zhu BT: Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms Endocrinology 2003, 144:3382-3398.
37. Cavalieri EL, Rogan EG: A unified mechanism in the initiation of cancer. Ann N Y Acad Sci 2002, 959:341-354.
38. Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D: Estrogens as endogenous genotoxic agents: DNA adducts and mutations. J Natl Cancer Inst Monogr 2000, 27:75-93.
39. Cavalieri EL, Kumar S, Todorovic R, Higginbotham S, Badawi AF, Rogan EG: Imbalance of estrogen homeostasis in kidney and liver of hamsters treated with estradiol: implications for estrogen-induced initiation of renal tumors. Chem Res Toxicol 2001, 14: 041-1050.
40. Cavalieri EL, Li KM, Balu N, Saeed M, Devanesan P, Higginbotham S, Zhao J, Gross ML, Rogan EG: Catechol orthoquinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases. Carcinogenesis 2002, 23: 071-1077.
41. Rogan EG, Badawi AF, Devanesan PD, Meza JL, Edney JA, West WW, Higginbotham SM, Cavalieri EL: Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer. Carcinogenesis 2003, 24:697-702.
42. Liehr JG: Is estradiol a genotoxic mutagenic carcinogen? Endocr Rev 2000, 21:40-54.
43. Dawling S, Roodi N, Mernaugh RL, Wang X, Pari FF: Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms. Cancer Res 2001, 61:6716-6722.
44. Goodman JE, Jensen LT, He P, Yager JD: Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation. Pharmacogenetics 2002, 12:517-528.
45. D'Amato RJ, Lin CM, Flynn E, Folkman J, Hamel E: 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc Nail Acad Sci USA 1994, 91:3964-3968.
46. Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nawroth PP, Schweigerer L: The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth Nature 1994, 368:237-239.
47. Lakhani NJ, Sarkar MA, Venitz J, Figg WD: 2-Methoxyestradiol, a promising anticancer agent. Pharmacotherapy 2003, 23:165-172.
48. Mackenzie PI, Owens IS, Burchell B, Bock KW, Bairoch A, Belanger A, Fournel-Gigleux S, Green M, Hum DW, Iyanagi T, et al.: The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 1997, 7:255-269.
49. Tukey RH, Strassburg CP: Genetic multiplicity of the human UDP-glucuronosyltransferases and regulation in the gastrointestinal tract Mol Pharmacol 2001, 59:405-414.
50. Guillemette C: Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. Pharmacogenomics J 2003, 3:136-158.
51. Fisher MB, Paine MF, Strelevitz TJ, Wrighton SA: The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism. Drug Metab Rev 2001, 33:273-297.
52. Gong QH, Cho JW, Huang T, Potter C, Gholami N, Basu NK, Kubota S, Carvalho S, Pennington MW, Owens IS, et al.: Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics 2001, 11:357-368.
53. Monaghan G, Clarke DJ, Povey S, See CG, Boxer M, Burchell B: Isolation of a human YAC contig encompassing a cluster of UGT2 genes and its regional localization to chromosome 4q13. Genomics 1994, 23:496-499.
54. Turgeon D, Carrier JS, Levesque E, Beatty BG, Belanger A, Hum DW: Isolation and characterization of the human UGT2B15 gene, localized within a cluster of UGT2B genes and pseudogenes on chromosome 4 J Mol Biol 2000, 295: 489-504.
55. Beaulieu M, Levesque E, Tchernof A, Beatty BG, Belanger A, Hum DW: Chromosomal localization, structure, and regulation of the UGT2B17 gene, encoding a C19 steroid metabolizing enzyme. DNA Cell Biol 1997, 16:1143-1154.
56. Owens IS, Ritter JK: Gene structure at the human UGT1 locus creates diversity in isozyme structure, substrate specificity, and regulation. Prog Nucleic Acid Res Mol Biol 1995, 51: 05-338.
57. Ritter JK, Chen F, Sheen YY, Tran HM, Kimura S, Yeatman MT, Owens IS: A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J Biol Chem 1992, 267:3257-3261.
58. Tukey RH, Strassburg CP: Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 2000, 40:581-616.
59. Jedlitschky G, Cassidy AJ, Sales M, Pratt N, Burchell B: Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase. Biochem J 1999, 340:837-843.
60. Lazard D, Zupko K, Poria Y, Nef P, Lazarovits J, Horn S, Khen M, Lancet D: Odorant signal termination by olfactory UDP glucuronosyl transferase. Nature 1991, 349:790-793.
61. Hum DW, Belanger A, Levesque E, Barbier O, Beaulieu M, Albert C, Vallee M, Guillemette C, Tchernof A, Turgeon D, et al.: Characterization of UDP-glucuronosyltransferases active on steroid hormones. J Steroid Biochem Mol Biol 1999, 69:413-423.
62. Liu J, Liu Y, Barter RA, Klaassen CD: Alteration of thyroid homeostasis by UDP-glucuronosyltransferase inducers in rats: a dose-response study. J Pharmacol Exp Ther 1995, 273: 77-985.
63. Dutton GJ: Glucuronidation of Drugs and Other Compounds Boca Raton, FL: CRC Press; 1980.
64. Jude AR, Little JM, Bull AW, Podgorski I, Radominska-Pandya A: 13-hydroxy- and 13-oxooctadecadienoic acids: novel substrates for human UDP-glucuronosyltransferases. Drug Metab Dispos 2001, 29:652-655.
65. Belanger A, Pelletier G, Labrie F, Barbier O, Chouinard S: Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. Trends Endocrinol Metab 2003, 14:473-479.
66. Lepine J, Bernard O, Plante M, Têtu B, Labrie F, Pelletier G, Bélanger A, Guillemette C: Specificity and regioselectivity of the conjugation of estradiol, estrone and their catechol estrogen and methoxyestrogen metabolites by human uridine diphosphoglucuronosyltransferases expressed in endometrium. J Clin Endocrinol Metab 2004:in press.
67. Gall WE, Zawada G, Mojarrabi B, Tephly TR, Green MD, Coffman BL, Mackenzie PI, Radominska-Pandya A: Differential glucuronidation of bile acids, androgens and estrogens by human UGT1A3 and 2B7. J Steroid Biochem Mol Biol 1999, 70: 101-108.
68. Cheng Z, Rios GR, King CD, Coffman BL, Green MD, Mojarrabi B, Mackenzie PI, Tephly TR: Glucuronidation of catechol estrogens by expressed human UDP-glucuronosyltransferases (UGTs) 1A1, 1A3, and 2B7. Toxicol Sci 1998, 45:52-57.
69. Wells PG, Mackenzie PI, Chowdhury JR, Guillemette C, Gregory PA, Ishii Y, Hansen AJ, Kessler FK, Kim PM, Chowdhury NR, et al.: Glucuronidation and the UDP-glucuronosyltransferases in health and disease. Drug Metab Dispos 2004, 32:281-290.
70. King CD, Green MD, Rios GR, Coffman BL, Owens IS, Bishop WP, Tephly TR: The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1. Arch Biochem Biophys 1996, 332:92-100.
71. Williams JA, Ring BJ, Cantrell VE, Campanale K, Jones DR, Hall SD, Wrighton SA: Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes. Drug Metab Dispos 2002, 30:1266-1273.
72. Soars MG, Ring BJ, Wrighton SA: The effect of incubation conditions on the enzyme kinetics of udp-glucuronosyltransferases. Drug Metab Dispos 2003, 31:762-767.
73. Senafi SB, Clarke DJ, Burchell B: Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation. Biochem J 1994, 303: 33-240.
74. Fisher MB, Vandenbranden M, Findlay K, Burchell B, Thummel KE, Hall SD, Wrighton SA: Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank. Pharmacogenetics 2000, 10:727-739.
75. Albert C, Vallee M, Beaudry G, Belanger A, Hum DW: The monkey and human uridine diphosphate-glucuronosyltransferase UGT1A9, expressed in steroid target tissues, are estrogen-conjugating enzymes. Endocrinology 1999, 140:3292-3302.
76. Mojarrabi B, Butler R, Mackenzie PI: cDNA cloning and characterization of the human UDP glucuronosyltransferase, UGT1A3. Biochem Biophys Res Commun 1996, 225:785-790.
77. Belanger A, Caron S, Labrie F, Naldoni C, Dogliotti L, Angeli A: Levels of eighteen non-conjugated and conjugated steroids in human breast cyst fluid: relationships with cyst type. Eur J Cancer 1990, 26:277-281.
78. Haiman CA, Hankinson SE, De Vivo I, Guillemette C, Ishibe N, Hunter DJ, Byrne C: Polymorphisms in steroid hormone pathway genes and mammographic density. Breast Cancer Res Treat 2003, 77: 7-36.
79. UDP Glucuronosyltransferase Nomenclature Committee: 1A1 alleles. [http://som.flinders.edu.au/FUSA/ClinPharm/UGT/1A1alleles.html]
80. Beutler E, Gelbart T, Demina A: Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci USA 1998, 95:8170-8174.
81. Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, Oostra BA, Lindhout D, Tytgat GN, Jansen PL, Oude Elferink RP, et al.: The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 1995, 333:1171-1175.
82. Monaghan G, Ryan M, Seddon R, Hume R, Burchell B: Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet 1996, 347:578-581.
83. Iolascon A, Faienza MF, Centra M, Storelli S, Zelante L, Savoia A: (TA)8 allele in the UGT1A1 gene promoter of a Caucasian with Gilbert's syndrome. Haematologica 1999, 84:106-109.
84. Nandi S, Guzman RC, Yang J: Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc Natl Acad Sci USA 1995, 92:3650-3657.
85. Lopez-Otin C, Diamandis EP: Breast and prostate cancer: an analysis of common epidemiological, genetic, and biochemical features. Endocr Rev 1998, 19:365-396.
86. Lower EE, Blau R, Gazder P, Stahl DL: The effect of estrogen usage on the subsequent hormone receptor status of primary breast cancer. Breast Cancer Res Treat 1999, 58:205-211.
87. Coffman BL, Rios GR, King CD, Tephly TR: Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab Dispos 1997, 25:1-4.
88. Albin N, Massaad L, Toussaint C, Mathieu MC, Morizet J, Parise O, Gouyette A, Chabot GG: Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues. Cancer Res 1993, 53:3541-3546.
89. Iscan M, Klaavuniemi T, Coban T, Kapucuoglu N, Pelkonen O, Raunio H: The expression of cytochrome P450 enzymes in human breast tumours and normal breast tissue. Breast Cancer Res Treat 2001, 70:47-54.
90. Muskhelishvili L, Thompson PA, Kusewitt DF, Wang C, Kadlubar FF: In situ hybridization and immunohistochemical analysis of cytochrome P450 1B1 expression in human normal tissues. J Histochem Cytochem 2001, 49:229-236.